| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0046-8177(97)90133-7 |
| P698 | PubMed publication ID | 9042799 |
| P2093 | author name string | G C Finkel | |
| E Olmsted | |||
| E Shore | |||
| F H Gannon | |||
| F S Kaplan | |||
| M A Zasloff | |||
| P2860 | cites work | Genetic aspects of fibrodysplasia ossificans progressiva | Q24517833 |
| Bone morphogenetic protein: chromosomal localization of human genes for BMP1, BMP2A, and BMP3 | Q28269316 | ||
| The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms | Q34349039 | ||
| Fibrodysplasia ossificans progressiva: a clue from the fly? | Q37823239 | ||
| Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. | Q52099922 | ||
| Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. | Q52211310 | ||
| The expression of platelet-derived growth-factor gene in Dupuytren contracture | Q60146954 | ||
| The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients | Q70536394 | ||
| Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody | Q71604901 | ||
| Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing | Q71848771 | ||
| The histopathology of fibrodysplasia ossificans progressiva. An endochondral process | Q72068101 | ||
| Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva | Q72240988 | ||
| Spinal deformity in patients who have fibrodysplasia ossificans progressiva | Q72724919 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | morphogenesis | Q815547 |
| fibrodysplasia ossificans progressiva | Q1410831 | ||
| P304 | page(s) | 339-343 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Human Pathology | Q15756731 |
| P1476 | title | Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. | |
| P478 | volume | 28 |
| Q36810299 | A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton |
| Q35568492 | Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification |
| Q35625198 | Apyrase as a novel therapeutic inhibitor of heterotopic ossification |
| Q30305648 | Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review |
| Q30373949 | Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1 |
| Q37119764 | Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. |
| Q79074088 | Contrast-Enhanced MRI of an Early Preosseous Lesion of Fibrodysplasia Ossificans Progressiva in a 21-Month-Old Boy |
| Q37733728 | Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury. |
| Q36532506 | Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva |
| Q41726396 | Encrypted morphogens of skeletogenesis: biological errors and pharmacologic potentials |
| Q37105402 | Fibrodysplasia ossificans progressiva |
| Q34146060 | Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. |
| Q37716166 | Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons |
| Q53140324 | Fibrodysplasia ossificans progressiva: initial presentation with a preosseous lesion of the scalp and its MRI appearance. |
| Q34644842 | Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis |
| Q54546270 | Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1. |
| Q47760064 | Fibrosarcoma: a historic commentary |
| Q39156140 | Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis |
| Q33555767 | From mysteries to medicines: drug development for fibrodysplasia ossificans progressive |
| Q31057631 | Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance |
| Q36981608 | Granting immunity to FOP and catching heterotopic ossification in the Act. |
| Q81140531 | Heterotopic ossification: a review |
| Q34790572 | Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP) |
| Q33960879 | Is there a biological basis for treatment of fibrodysplasia ossificans progressiva with rosiglitazone? Potential benefits and undesired effects. |
| Q47814723 | Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). |
| Q35212915 | Molecular and cellular mechanisms of heterotopic ossification |
| Q36682824 | Nanogel-Mediated RNAi Against Runx2 and Osx Inhibits Osteogenic Differentiation in Constitutively Active BMPR1A Osteoblasts |
| Q28594900 | Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP |
| Q64097643 | Osteogenic differentiation of skeletal muscle progenitor cells is activated by the DNA damage response |
| Q74172123 | Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts |
| Q34201678 | Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle |
| Q28286551 | Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations |
| Q80167781 | Pre- and post-therapy MR imaging in fibrodysplasia ossificans progressiva |
| Q77582000 | Regulation of chondrocyte differentiation and maturation |
| Q38639065 | Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases |
| Q36749575 | Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP) |
| Q36593023 | Sporadic Fibrodysplasia Ossificans Progressiva in an Egyptian Infant with c.617G > A Mutation in ACVR1 Gene: A Case Report and Review of Literature |
| Q36242266 | The BMP signaling and in vivo bone formation |
| Q34020080 | The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling |
| Q37403100 | The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization |
| Q34347716 | The revolution in human monogenic disease mapping |
| Q47447929 | Variable signaling activity by FOP ACVR1 mutations |
| Q36768869 | When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). |
Search more.